Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT05526248
Title A Study Called ARAMON to Learn to What Extent Does Study Treatment With Darolutamide Affects Testosterone Levels in Men With Prostate Cancer That Had Not Been Treated With Hormonal Therapy Compared to Treatment With Enzalutamide (ARAMON)
Acronym ARAMON
Recruitment Recruiting
Gender male
Phase Phase II
Variant Requirements No
Sponsors Bayer
Indications
Therapies
Age Groups: senior | adult
Covered Countries USA

Facility Status City State Zip Country Details
Genesis Research LLC NOT_YET_RECRUITING Sherman Oaks California 91411 United States Details
Massachusetts General Hospital RECRUITING Boston Massachusetts 02114-2696 United States Details
Beth Israel Deaconess Medical Center - Boston NOT_YET_RECRUITING Boston Massachusetts 02215 United States Details
Memorial Sloan Kettering Cancer Center NOT_YET_RECRUITING New York New York 10021-0005 United States Details
Central Ohio Urology Group NOT_YET_RECRUITING Columbus Ohio 43214-2416 United States Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field